Aurora Cannabis Inc., a leading global medical cannabis company, announced it will release its financial results for the first quarter of fiscal year 2027 on August 5, 2026, before market open. The company will host an investor conference call the same day at 8:00 a.m. Eastern Time to discuss the results, led by CEO Miguel Martin and CFO Simona King. This event is important for investors to gain insights into Aurora's financial health and strategic outlook amid its global operations and market expansion efforts.
Aurora Cannabis has received an unsolicited takeover proposal from Curaleaf offering $4 per share, combining cash and Curaleaf shares. Aurora's board is reviewing the offer carefully, noting the price is lower than past trading values and emphasizing...
Curaleaf Holdings has made a hostile bid to acquire Aurora Cannabis, proposing $4 per share through a combination of Curaleaf shares and $0.75 cash per Aurora share. This offer represents a 45% premium over Aurora's recent average price and aims to m...
Curaleaf Holdings has proposed to acquire Aurora Cannabis by offering US$4.00 per share, including cash and Curaleaf shares, representing a 45% premium over Aurora's recent trading price. The deal aims to combine Aurora's EU-GMP cultivation and manuf...
Aurora Cannabis held its 2026 Annual General Meeting virtually, with 26.86% of shares represented. Shareholders re-elected all nominated directors with over 85% approval and approved Ernst & Young LLP as auditors for the coming year. The advisory vot...
